fda compounding semaglutide enforcement 2025 news issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Report: FDA must enforce rules

Stress-induced eating in rats

Track your GLP-1 treatment week by week and stay motivated as you move toward your GLP1 goals

That is the entire conversion

In addition, incretin enthusiasts had suffered a serious disappointment, when it was observed, at about the same time, that GIP although being potently insulinotropic in healthy individuals was ineffective in patients with type 2 diabetes (58)

In 2014, the Stimulation Therapy for Apnea Reduction (STAR) trial found that, among patients with moderate-to-severe OSA and a body mass index (BMI) of less than 32 kg/m 2 , unilateral hypoglossal nerve stimulation led to a 68% reduction in OSA severity (based on AHI) at 12 months, and improvements in sleepiness scores [44]

LAURIE SUND: Well, I think 42% of our population has obesity